61 related articles for article (PubMed ID: 1465283)
1. Changes in the Ki-67 labeling rates of head and neck squamous cell carcinomas during preoperative radiation therapy.
Ogawa Y; Inomata T; Nishioka A; Maeda T; Seguchi H; Kishimoto S; Saito H; Hirota J; Osaki T
Oncology; 1992; 49(6):450-3. PubMed ID: 1465283
[TBL] [Abstract][Full Text] [Related]
2. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labeling indices.
Oka K; Nakano T; Hoshi T
Cancer; 1996 Jun; 77(11):2280-5. PubMed ID: 8635096
[TBL] [Abstract][Full Text] [Related]
3. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Ki-67 and PC10 immunostaining.
Oka K; Nakano T; Hoshi T
Cancer; 1993 Nov; 72(9):2621-7. PubMed ID: 8402484
[TBL] [Abstract][Full Text] [Related]
4. [Expression of HLA-DR antigen on head and neck carcinomas--immunohistological study].
Samukawa T
Nihon Jibiinkoka Gakkai Kaiho; 1993 Jan; 96(1):88-97. PubMed ID: 8459313
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of c-fos-positive lymphocytes infiltrated into human squamous cell carcinomas of the head and neck during radiation therapy and its clinical significance.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2301-7. PubMed ID: 9815628
[TBL] [Abstract][Full Text] [Related]
6. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of proliferative activity in human head and neck tumors using the monoclonal antibody Ki-67.
Lörz M; Meyer-Breiting E
ORL J Otorhinolaryngol Relat Spec; 1988; 50(3):183-7. PubMed ID: 3405598
[TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical staining of proliferating cells in endoscopically biopsied tissues of gastric carcinomas with monoclonal antibody Ki-67.
Yonemura Y; Kimura H; Ooyama S; Kamata T; Yamaguchi A; Matsumoto H; Ninomiya I; Miyazaki I
Oncology; 1991; 48(2):162-5. PubMed ID: 1997941
[TBL] [Abstract][Full Text] [Related]
11. Expression of fas (CD95/APO-1) antigen induced by radiation therapy for diffuse B-cell lymphoma: immunohistochemical study.
Ogawa Y; Nishioka A; Hamada N; Terashima M; Inomata T; Yoshida S; Seguchi H; Kishimoto S
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2211-6. PubMed ID: 9815617
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity of squamous cell carcinoma metastases to the neck assessed by immunocytochemical profiling of fine-needle aspiration biopsy cell specimens: a pilot study.
Flezar MS; Kirbis IS; Popović KS; Strojan P
Radiother Oncol; 2009 Dec; 93(3):575-80. PubMed ID: 19850367
[TBL] [Abstract][Full Text] [Related]
13. Transition of Ki-67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study.
Nakano T; Oka K
Cancer; 1991 Aug; 68(3):517-23. PubMed ID: 2065270
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
[TBL] [Abstract][Full Text] [Related]
15. Dose-response relationship for elective neck irradiation of head and neck cancer--facts and controversies.
Suwinski R; Maciejewski B; Withers HR
Neoplasma; 1998; 45(2):107-12. PubMed ID: 9687892
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study of p53 expression in cancer tissues from patients undergoing radiation therapy.
Hamada N; Ogawa Y; Seguchi H; Terashima M; Nishioka A; Inomata T; Yoshida S; Kishimoto S; Saito H
Histol Histopathol; 1995 Jul; 10(3):611-7. PubMed ID: 7579809
[TBL] [Abstract][Full Text] [Related]
17. Expression of a nuclear envelope protein recognized by the monoclonal antibody BU31 in lung tumours: relationship to Ki-67 antigen expression.
Rowlands DC; Bunce CM; Crocker J; Ayres JG; Johnson GD; Ling N; Brown G
J Pathol; 1994 Jun; 173(2):89-96. PubMed ID: 8089810
[TBL] [Abstract][Full Text] [Related]
18. Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.
Kao J; Genden EM; Gupta V; Policarpio EL; Burri RJ; Rivera M; Gurudutt V; Som PM; Teng M; Packer SH
Cancer; 2011 Jan; 117(2):318-26. PubMed ID: 20830768
[TBL] [Abstract][Full Text] [Related]
19. Can Ki67 immunostaining predict response to radiotherapy in oral squamous cell carcinoma?
Valente G; Orecchia R; Gandolfo S; Arnaudo M; Ragona R; Kerim S; Palestro G
J Clin Pathol; 1994 Feb; 47(2):109-12. PubMed ID: 8132823
[TBL] [Abstract][Full Text] [Related]
20. Cytologic assessment of tumor cell kinetics: applications of monoclonal antibody Ki-67 to fine-needle aspiration smears.
Henry MJ; Stanley MW; Swenson B; Connolly JE; Bates H
Diagn Cytopathol; 1991; 7(6):591-6. PubMed ID: 1769287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
